Literature DB >> 33301070

[Enhanced imaging in urological endoscopy].

M C Kriegmair1, S Hein2, D S Schoeb2, H Zappe3, R Suárez-Ibarrola2, F Waldbillig4, B Gruene4, P-F Pohlmann2, F Praus2, K Wilhelm2, C Gratzke2, A Miernik2, C Bolenz5.   

Abstract

White light cystoscopy and the concise documentation of pathological findings are standard diagnostic procedures in urology. Additional imaging modalities and technical innovations may support clinicians in the detection of bladder tumors. Modern endoscopy systems provide ultra-high-resolution imaging and the option of digital contrast enhancement. Photodynamic diagnostics and narrow band imaging are well-established in clinical routine and have shown significant benefits in the detection of bladder cancer. By means of multispectral imaging, different modalities can now be combined in real-time. Probe-based procedures such as optical coherence tomography (OCT) or Raman spectroscopy can further contribute to advanced imaging through an "optical biopsy" which may primarily improve diagnostics in the upper urinary tract. The aim of all techniques is to optimize the detection rate in order to achieve a more accurate diagnosis, resection and lower recurrence rates. Current research projects aim to digitalize the documentation of endoscopy and also make it more patient- and user-friendly. In the future, the use of image processing and artificial intelligence may automatically support the surgeon during endoscopy.

Entities:  

Keywords:  Bladder cancer; Cystscopy; Fluorescence; Photodynamic imaging; Urothelial carcinoma

Mesh:

Year:  2020        PMID: 33301070     DOI: 10.1007/s00120-020-01400-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  38 in total

1.  Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder.

Authors:  S J Cina; J I Epstein; J M Endrizzi; W J Harmon; T M Seay; M P Schoenberg
Journal:  Hum Pathol       Date:  2001-06       Impact factor: 3.466

2.  Comparison of resolution, contrast, and color differentiation among fiberoptic and digital flexible cystoscopes.

Authors:  James F Borin; Corollos S Abdelshehid; Ralph V Clayman
Journal:  J Endourol       Date:  2006-01       Impact factor: 2.942

3.  Current European Trends in Endoscopic Imaging and Transurethral Resection of Bladder Tumors.

Authors:  Frank Waldbillig; Simon Hein; Britta Grüne; Rodrigo Suarez-Ibarrola; Evangelos Liatsikos; Georg Salomon; Alexander Reiterer; Christian Gratzke; Arkadiusz Miernik; Maximilian C Kriegmair; Manuel Ritter
Journal:  J Endourol       Date:  2019-11-19       Impact factor: 2.942

4.  Correction to: Enhanced Endoscopy in Bladder Cancer.

Authors:  Shane Pearce; Siamak Daneshmand
Journal:  Curr Urol Rep       Date:  2019-04-05       Impact factor: 3.092

Review 5.  Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel.

Authors:  Viktor Soukup; Otakar Čapoun; Daniel Cohen; Virginia Hernández; Maximilian Burger; Eva Compérat; Paolo Gontero; Thomas Lam; A Hugh Mostafid; Joan Palou; Bas W G van Rhijn; Morgan Rouprêt; Shahrokh F Shariat; Richard Sylvester; Yuhong Yuan; Richard Zigeuner; Marek Babjuk
Journal:  Eur Urol Focus       Date:  2018-11-22

6.  Expression of ferrochelatase has a strong correlation in protoporphyrin IX accumulation with photodynamic detection of bladder cancer.

Authors:  Yasushi Nakai; Yoshihiro Tatsumi; Makito Miyake; Satoshi Anai; Masaomi Kuwada; Sayuri Onishi; Yoshitomo Chihara; Nobumichi Tanaka; Yoshihiko Hirao; Kiyohide Fujimoto
Journal:  Photodiagnosis Photodyn Ther       Date:  2015-07-28       Impact factor: 3.631

Review 7.  Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data.

Authors:  Maximilian Burger; H Barton Grossman; Michael Droller; Joerg Schmidbauer; Gregers Hermann; Octavian Drăgoescu; Eleanor Ray; Yves Fradet; Alexander Karl; Juan Pablo Burgués; J Alfred Witjes; Arnulf Stenzl; Patrice Jichlinski; Dieter Jocham
Journal:  Eur Urol       Date:  2013-04-08       Impact factor: 20.096

Review 8.  [Future requirements for oncological care: Challenges due to demographic change].

Authors:  B Wörmann
Journal:  Urologe A       Date:  2015-12       Impact factor: 0.639

9.  Current Standards in the Endoscopic Management of Bladder Cancer: A Survey Evaluation among Urologists in German-Speaking Countries.

Authors:  Rodrigo Suarez-Ibarrola; Simon Hein; Erik Farin; Frank Waldbillig; Maximilian C Kriegmair; Manuel Ritter; Hans C Klingler; Thomas R W Herrmann; Christian Gratzke; Arkadiusz Miernik
Journal:  Urol Int       Date:  2020-03-25       Impact factor: 2.089

Review 10.  European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.

Authors:  Marko Babjuk; Maximilian Burger; Eva M Compérat; Paolo Gontero; A Hugh Mostafid; Joan Palou; Bas W G van Rhijn; Morgan Rouprêt; Shahrokh F Shariat; Richard Sylvester; Richard Zigeuner; Otakar Capoun; Daniel Cohen; José Luis Dominguez Escrig; Virginia Hernández; Benoit Peyronnet; Thomas Seisen; Viktor Soukup
Journal:  Eur Urol       Date:  2019-08-20       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.